acut
lower
respiratori
tract
infect
major
caus
pediatr
morbid
mortal
worldwid
annual
account
million
death
children
year
age
occur
develop
world
william
et
al
black
et
al
past
respiratori
syncyti
viru
rsv
paramyxovirida
influenza
virus
b
orthomyxovirida
parainfluenza
virus
piv
paramyxovirida
adenovirus
adenovirida
view
lead
viral
caus
acut
lower
respiratori
tract
infect
law
et
al
crow
william
sinc
sever
novel
respiratori
virus
describ
includ
human
metapneumoviru
hmpv
van
den
hoogen
et
al
paramyxovirida
human
coronavirus
hcov
van
der
hoek
et
al
woo
et
al
coronavirida
human
bocaviru
hbov
alland
et
al
parvovirida
two
new
polyomavirus
wu
viru
wuv
ki
viru
kiv
alland
et
al
bialasiewicz
et
al
gaynor
et
al
polyomavirida
furthermor
improv
sensit
diagnost
test
lead
increas
detect
virus
previous
consid
upper
respiratori
tract
infect
case
acut
lower
respiratori
tract
diseas
includ
rhinoviru
famili
picornavirida
pene
et
al
vabret
et
al
jartti
et
al
hayden
bries
et
al
respiratori
virus
import
caus
morbid
mortal
immunocompromis
individu
includ
patient
acquir
immunodefici
syndrom
wwwunaidsorg
unaid
increas
diseas
burden
due
rsv
madhi
et
al
madhi
et
al
hmpv
madhi
et
al
infect
demonstr
children
infect
hiv
yet
comparison
comprehens
rang
newli
implic
virus
well
well
defin
respiratori
virus
sensit
molecular
techniqu
lack
subsaharan
african
countri
individu
infect
hiv
resid
unaid
recent
studi
kenya
indic
rsv
account
major
respiratori
infect
young
children
berkley
et
al
data
yet
avail
role
rhinoviru
new
virus
hospit
patient
african
contin
season
distribut
individu
virus
temper
region
south
africa
contribut
virus
hospit
singl
coinfect
diseas
sever
hospit
children
popul
high
hiv
diseas
burden
also
yet
defin
investig
contribut
new
common
respiratori
virus
hospit
children
year
age
south
africa
pcr
assay
differ
respiratori
virus
use
screen
specimen
patient
seek
medic
attent
requir
hospit
public
sector
hospit
serv
pretoria
area
south
africa
period
year
compar
healthi
control
group
age
region
season
trend
age
distribut
coinfect
rate
associ
singl
mix
infect
diseas
sever
assess
hiv
seroposit
neg
children
region
total
respiratori
specimen
respect
submit
test
routin
viru
diagnosi
depart
medic
virolog
univers
pretorianhl
tshwane
academ
divis
serv
three
public
sector
hospit
pretoria
region
viz
steve
biko
academ
hospit
kalafong
secondari
hospit
hospit
nasopharyng
aspir
collect
day
admiss
total
specimen
group
patient
patient
requir
hospit
tabl
specimen
receiv
children
less
year
age
reason
specimen
children
includ
studi
throughout
year
specimen
previous
test
neg
togeth
specimen
test
posit
routin
antigen
detect
assay
randomli
select
retrospect
screen
rtpcr
assay
repres
approxim
onethird
total
specimen
receiv
year
tabl
list
demograph
studi
group
clinic
diseas
sever
retrospect
record
patient
hospit
file
broadli
categor
outpati
basi
patient
present
emerg
room
requir
admiss
hospit
patient
ill
enough
admit
pediatr
ward
patient
need
icu
treatment
control
specimen
nasopharyng
aspir
collect
follow
written
inform
consent
healthi
children
year
age
similar
epidemiolog
background
attend
vaccin
clinic
region
prior
specimen
collect
parent
vaccin
clinic
ask
complet
questionnair
regard
occurr
symptom
associ
respiratori
diseas
within
previou
month
healthi
children
without
recent
respiratori
diseas
includ
healthi
control
group
antigen
detect
assay
routin
diagnosi
perform
direct
immunofluoresc
assay
use
light
diagnost
tm
respiratori
panel
viral
screen
identif
kit
millipor
billerica
detect
rsv
b
influenza
b
adenoviru
light
diagnost
tm
cytomegaloviru
cmv
immunofluoresc
assay
millipor
billerica
rapid
rsv
antigen
detect
elisa
bd
directigen
tm
rsv
test
bd
franklin
lake
nj
perform
request
attend
clinician
includ
patient
suffer
acut
respiratori
tract
infect
respiratori
sampl
randomli
select
throughout
year
screen
multiplex
realtim
rtpcr
assay
c
hiv
seroposit
expos
dna
pcr
posit
patient
infect
includ
nucleic
acid
extract
nucleic
acid
extract
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
mannheim
germani
cdna
synthesi
cdna
synthes
use
random
hexam
primer
expand
revers
transcriptas
roch
diagnost
accord
manufactur
instruct
multiplex
real
time
rtpcr
twostep
multiplex
realtim
reversetranscriptas
rt
pcr
detect
quantit
respiratori
virus
perform
previous
describ
brief
four
multiplex
pcr
assay
target
rsv
hmpv
hbov
multiplex
multiplex
influenza
b
adenoviru
multiplex
multiplex
run
roch
light
cycler
roch
diagnost
rhinoviru
rtpcr
rhinoviru
detect
convent
nest
rtpcr
first
round
rtpcr
perform
titan
onetub
rtpcr
system
roch
diagnost
use
primer
coira
et
al
brief
ml
rna
ad
ml
reaction
buffer
mm
dtt
solut
pmol
primer
mm
dntp
ml
titan
tm
enzym
mix
u
protector
rnase
inhibitor
roch
diagnost
ml
q
solut
qiagen
hilden
germani
final
volum
ml
reaction
perform
accord
follow
program
min
min
sec
min
sec
cycl
min
nest
pcr
perform
expand
high
fidel
plu
pcr
system
roch
diagnost
use
primer
hrv
arden
et
al
kindli
provid
dr
thoma
bries
w
ian
lipkin
columbia
univers
new
york
nest
pcr
conduct
ml
reaction
use
ml
rtpcr
product
mix
ml
reaction
buffer
mm
dntp
pmol
primer
u
expand
high
fidel
plu
enzym
mix
accord
follow
program
min
sec
sec
sec
cycl
min
cycl
perform
palmcycl
tm
version
corbett
research
sydney
australia
pcr
product
assess
agaros
gel
electrophores
data
analysi
determin
virus
describ
recent
account
undiagnos
respiratori
case
major
specimen
sampl
group
retrospect
screen
pcr
assay
select
ifa
neg
specimen
order
determin
accur
preval
rate
virus
alreadi
includ
ifa
assay
preval
determin
ifa
pcr
assay
extrapol
follow
convent
respiratori
virus
respect
viru
percentag
identifi
rtpcr
ifaneg
sampl
group
total
ifaneg
sampl
number
viru
present
ifaposit
group
total
number
specimen
studi
group
calcul
gave
similar
result
ad
posit
total
specimen
group
pcr
posit
neg
sampl
group
fisher
exact
test
use
compar
categor
data
includ
demograph
data
coinfect
rate
quantit
data
associ
differ
respiratori
virus
confid
level
mean
quantit
data
analyz
determin
student
ttest
twotail
distribut
statist
analys
perform
use
graphpad
instat
softwar
version
graphpad
softwar
san
diego
ca
period
specimen
submit
respiratori
viru
investig
routin
diagnost
laboratori
children
year
age
purpos
studi
select
randomli
everi
month
realtim
pcr
screen
children
year
age
use
investig
tabl
within
year
patient
select
studi
group
differ
significantli
complet
patient
group
respect
percentag
hospit
patient
age
sex
hiv
seropreval
patient
group
compar
hiv
seropreval
gauteng
provinc
south
africa
among
antenat
clinic
attende
wwwdohgovza
docsnasspsfhtml
although
patient
unknown
statu
sampl
patient
group
higher
hiv
seropreval
greater
number
patient
known
statu
due
subsequ
blind
test
unknown
sampl
part
anoth
studi
data
made
avail
studi
kresfeld
et
al
unpublish
data
venter
et
al
tabl
period
children
less
year
age
rhinoviru
account
respiratori
infect
follow
rsv
hbov
adenoviru
hmpv
influenza
influenza
b
detect
tabl
ii
wuv
detect
kiv
case
describ
previous
venter
et
al
compar
ifa
pcr
assay
identifi
distinctli
higher
coinfect
rate
rsv
vs
influenza
vs
vs
vs
adenoviru
vs
tabl
ii
except
influenza
adenoviru
recent
describ
virus
greater
number
coinfect
hmpv
hbov
tabl
ii
lower
coinfect
rate
observ
rhinoviru
rel
mani
recent
describ
convent
respiratori
virus
signific
rel
hmpv
hbov
adenoviru
p
comparison
healthi
control
patient
rhinoviru
detect
frequent
follow
rsv
hbov
adenoviru
patient
group
rhinoviru
detect
singl
infect
healthi
children
rsv
adenoviru
hbov
detect
singl
infect
one
patient
coinfect
rsv
hbov
rhinoviru
age
distribut
differ
respiratori
virus
children
attend
public
sector
hospit
pretoria
shown
figur
b
major
respiratori
virus
identifi
children
age
rsv
predomin
age
group
younger
year
equival
rhinoviru
children
month
rsv
rhinoviru
diseas
detect
children
month
age
hbov
adenoviru
infect
children
month
hpmv
infect
distribut
almost
equal
month
age
group
influenza
infect
identifi
month
age
group
detect
one
old
patient
two
patient
month
old
monthli
detect
individu
virus
indic
figur
climat
season
region
south
africa
distinguish
follow
summer
novemb
februari
autumn
march
may
winter
june
august
spring
septemberoctob
raini
season
octob
march
rsv
peak
autumn
aprilmay
detect
frequent
spring
august
octob
influenza
peak
april
septemb
major
case
june
juli
two
peak
aprilmay
augustseptemb
may
sampl
error
due
low
number
detect
hospit
children
year
adenoviru
distribut
throughout
year
rhinoviru
occur
throughout
year
peak
activ
observ
februari
may
aprilaugust
hmpv
occur
yearround
peak
activ
april
mayaugust
hbov
case
detect
throughout
wherea
peak
activ
occur
juli
octob
predominantli
detect
winter
junejuli
spring
septemberoctob
wherea
case
detect
midsumm
januari
midautumn
may
assess
convent
virus
patient
singl
infect
rsv
preval
convent
virus
complet
specimen
group
adjust
take
account
reduc
sensit
ifa
rel
complet
specimen
group
sinc
rtpcr
use
screen
mainli
specimen
alreadi
test
neg
ifa
ifa
posit
total
group
rtpcr
posit
neg
specimen
group
equival
extrapol
valu
calcul
follow
convent
respiratori
virus
respect
viru
percentag
identifi
rtpcr
ifaneg
sampl
group
total
ifaneg
sampl
number
viru
present
ifaposit
group
total
number
specimen
studi
group
tabl
iii
patient
recent
describ
virus
singl
hmpv
hbov
rhinoviru
infect
requir
hospit
tabl
iii
rhinoviru
rsv
account
singl
infect
result
hospit
associ
rsv
infect
singleand
coinfect
acut
lower
respiratori
tract
infect
hospit
highli
signific
compar
healthi
control
group
p
hospit
rate
rsv
rhinoviru
infect
patient
compar
significantli
rsv
singl
infect
patient
requir
intens
care
treatment
patient
infect
rhinoviru
p
singl
infect
rhinoviru
preval
neither
significantli
higher
patient
acut
respiratori
infect
hospit
patient
compar
singl
infect
healthi
control
group
p
respect
tabl
iii
howev
collect
frequenc
detect
rhinoviru
infect
singleand
coinfect
notabl
higher
patient
acut
respiratori
infect
show
total
number
specimen
receiv
month
specimen
posit
routin
diagnost
assay
sampl
group
screen
multiplex
number
posit
specimen
viru
shown
graph
indic
tradit
virus
detect
antigen
detect
test
new
virus
detect
screen
sampl
group
therefor
reflect
extrapol
frequenc
rather
actual
posit
sampl
group
select
randomli
month
tabl
iii
patient
rsv
rhinoviru
similar
hiv
seropreval
patient
coinfect
greater
percentag
patient
hospit
rel
singl
infect
influenza
adenoviru
hmpv
hbov
although
statist
signific
due
low
number
singl
infect
case
tabl
iiib
rsv
rhinoviru
significantli
higher
percentag
patient
singl
infect
tabl
iiia
hospit
coinfect
tabl
iiib
rsv
singl
vs
coinfect
rhinoviru
singl
vs
coinfect
p
respect
need
icu
treatment
p
respect
greater
percentag
patient
coinfect
hiv
seroposit
rel
singl
infect
patient
influenza
adenoviru
rhinoviru
hmpv
hbov
although
statist
signific
due
low
number
although
new
virus
detect
low
number
draw
signific
conclus
regard
diseas
present
clinic
data
investig
singl
infect
rsv
hrv
case
data
avail
compar
singl
influenza
hpmv
hbov
patient
tabl
iv
follow
observ
made
singl
infect
hbov
hmpv
detect
associ
respiratori
distress
crepit
wheez
gastrointestin
symptom
sever
case
lower
respiratori
tract
infect
diagnos
hmpv
hbov
patient
singl
infect
mani
patient
receiv
diagnosi
bronchiol
bronchopneumonia
pneumonia
hbov
also
detect
two
patient
upper
respiratori
tract
infect
singl
infect
rhinoviru
associ
wide
varieti
diagnos
rang
moder
upper
respiratori
tract
infect
sever
pneumonia
bronchiol
associ
sever
pneumonia
croup
prematur
patient
expos
hiv
admit
icu
detect
patient
suffer
apnea
attack
lower
respiratori
tract
infect
patient
bronchiol
detect
singl
infect
patient
admit
icu
due
lower
respiratori
tract
infect
apnea
attack
detect
coinfect
patient
suffer
bronchopneumonia
contribut
respiratori
virus
emerg
room
visit
hospit
children
investig
period
pretoria
region
gauteng
south
africa
data
lack
role
comprehens
rang
respiratori
virus
acut
lower
respiratori
tract
infect
southern
africa
well
role
hiv
infect
patient
particular
new
virus
routin
includ
routin
diagnost
test
signific
increas
sensit
realtim
rtpcr
rel
routin
antigen
detect
assay
demonstr
increas
detect
rate
convent
virus
new
virus
includ
routin
test
well
coinfect
current
studi
sampl
patient
group
rhinoviru
frequent
detect
viru
follow
rsv
hbov
hmpv
adenoviru
influenza
virus
detect
case
tabl
ii
wuv
also
detect
case
warrant
investig
venter
et
al
overal
preval
hmpv
hbov
compar
influenza
prepandem
season
well
adenoviru
coinfect
frequenc
particularli
high
patient
infect
recent
describ
respiratori
virus
although
high
coinfect
rate
also
observ
influenza
adenoviru
respect
collect
patient
test
posit
age
hiv
posit
reflect
demograph
patient
group
respiratori
specimen
submit
routin
diagnost
laboratori
hbov
infrequ
detect
patient
less
month
age
suggest
possibl
protect
role
matern
antibodi
worldwid
pediatr
acut
lower
respiratori
tract
infect
associ
hospit
frequent
associ
rsv
follow
influenza
forster
et
al
iwan
et
al
although
studi
suggest
hmpv
associ
hospit
rate
may
exceed
latter
two
virus
vicent
et
al
case
hospit
associ
singl
infect
children
studi
associ
rhinoviru
rsv
case
respect
hmpv
hbov
singl
influenza
adenoviru
case
hospit
singl
infect
result
death
highest
rsv
follow
rhinoviru
death
identifi
hpmv
hbov
investig
larger
patient
group
clarifi
associ
hospit
rate
newli
describ
virus
popul
high
hiv
burden
coinfect
virus
associ
increas
death
rate
studi
tabl
iii
rhinoviru
viru
detect
frequent
detect
addit
inform
could
obtain
two
infect
patient
viru
healthi
individu
may
signifi
prolong
shed
healthi
patient
howev
concord
recent
find
trento
et
al
rhinoviru
significantli
higher
detect
rate
children
respiratori
diseas
requir
medic
attent
compar
healthi
individu
vs
p
case
due
shed
would
suggest
rhinoviru
may
still
associ
hospit
case
rhinoviru
also
associ
sever
diseas
singl
infect
requir
oxygen
supplement
tabl
iv
appear
less
sever
rsvassoci
acut
lower
respiratori
tract
infect
report
similar
studi
linsuwanon
et
al
rhinoviru
infect
patient
requir
intens
care
treatment
compar
rsv
patient
prolong
shed
period
asymptomat
infect
may
account
high
detect
rate
healthi
children
warrant
investig
especi
patient
hiv
coinfect
kaiser
et
al
peltola
et
al
one
limit
studi
patient
consent
test
hiv
associ
diseas
sever
could
therefor
drawn
although
present
studi
indic
virus
associ
frequent
hospit
hiv
seroposit
patient
coinfect
observ
frequent
group
casecontrol
studi
hiv
cohort
may
determin
impact
virus
hospit
rate
hiv
seroposit
patient
compar
hivuninfect
patient
studi
also
demonstr
contribut
wide
rang
respiratori
virus
acut
respiratori
infect
differ
season
southern
africa
region
data
lack
mani
virus
major
case
autumn
earli
winter
march
juli
attribut
rsv
influenza
occur
mostli
winter
spring
hbov
peak
summer
spring
hmpv
autumn
winter
show
variabl
year
observ
season
distribut
appear
occur
mostli
late
summer
autumn
contrari
temper
region
mostli
observ
winter
arden
et
al
bastien
et
al
van
der
hoek
et
al
present
studi
appear
resembl
subtrop
region
lau
et
al
despit
small
number
detect
rhinoviru
found
year
round
conclus
sever
respiratori
virus
contribut
acut
lower
respiratori
tract
infect
hospit
differ
season
children
south
africa
compar
countri
significantli
lower
hivaid
burden
use
molecular
screen
techniqu
coinfect
identifi
much
frequent
although
associ
sever
diseas
rsv
demonstr
contribut
significantli
sever
acut
lower
respiratori
infect
previous
appreci
remain
import
viral
caus
acut
lower
respiratori
tract
infect
hospit
children
south
africa
